KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer

Por Waters, Andrew M., Der, Channing J.
Publicado no Cold Spring Harb Perspect Med (2018)

Single Synonymous Mutations in KRAS Cause Transformed Phenotypes in NIH(3)T(3) Cells

Por Waters, Andrew M., Bagni, Rachel, Portugal, Franklin, Hartley, James L.
Publicado no PLoS One (2016)

Antitumor Effects of Synthetic 6,7-Annulated-4-substituted Indole Compounds in L1210 Leukemic Cells In Vitro

Por PERCHELLET, JEAN-PIERRE H., WATERS, ANDREW M., PERCHELLET, ELISABETH M., THORNTON, PAUL D., BROWN, NEIL, HILL, DAVID, NEUENSWANDER, BEN, LUSHINGTON, GERALD H., SANTINI, CONRAD, CHANDRASOMA, NALIN, BUSZEK, KEITH R.
Publicado em 2012

Comparative proteomics of a model MCF10A-KRas(G12V) cell line reveals a distinct molecular signature of the KRas(G12V) cell surface

Por Ye, Xiaoying, Chan, King C., Waters, Andrew M., Bess, Matthew, Harned, Adam, Wei, Bih-Rong, Loncarek, Jadranka, Luke, Brian T., Orsburn, Benjamin C., Hollinger, Bradley D., Stephens, Robert M., Bagni, Rachel, Martinko, Alex, Wells, James A., Nissley, Dwight V., McCormick, Frank, Whiteley, Gordon, Blonder, Josip
Publicado no Oncotarget (2016)

Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies

Por Waters, Andrew M., Ozkan-Dagliyan, Irem, Vaseva, Angelina V., Fer, Nicole, Strathern, Leslie A., Hobbs, G. Aaron, Tessier-Cloutier, Basile, Gillette, William K., Bagni, Rachel, Whiteley, Gordon R., Hartley, James L., McCormick, Frank, Cox, Adrienne D., Houghton, Peter J., Huntsman, David G., Philips, Mark R., Der, Channing J.
Publicado no Sci Signal (2017)